ALS patients with mutations in the SOD1 gene have an unique metabolomic profile in the cerebrospinal fluid compared with ALS patients without mutations

Molecular Genetics and Metabolism

Volumn 105, Issue 3, 2012, Pages 472-478

  Wuolikainen, Anna ^a   Andersen, Peter M ^a   Moritz, Thomas ^b   Marklund, Stefan L ^a   Antti, Henrik ^a  

^a UMEÅ UNIVERSITY   (Sweden)

^b SWEDISH UNIVERSITY OF AGRICULTURAL SCIENCES   (Sweden)

Author keywords

Amyotrophic lateral sclerosis (ALS); Biomarker; Cerebrospinal fluid (CSF); Chemometrics; D90A SOD1; Metabolomics

Indexed keywords

ARGININE; LYSINE; ORNITHINE; PYROGLUTAMIC ACID; RILUZOLE; SERINE; SUPEROXIDE DISMUTASE; THREONINE;

ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; CEREBROSPINAL FLUID; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; FEMALE; GENE MUTATION; GENETIC ANALYSIS; HOMOZYGOSITY; HUMAN; MALE; METABOLOMICS; PRIORITY JOURNAL; SURVIVAL TIME;

ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; FEMALE; GENOTYPE; HUMANS; MALE; METABOLOME; METABOLOMICS; MIDDLE AGED; MUTATION; RILUZOLE; SUPEROXIDE DISMUTASE;

EID: 84858280794     PISSN: 10967192     EISSN: 10967206     Source Type: Journal    
DOI: 10.1016/j.ymgme.2011.11.201     Document Type: Article

References (30)

1. Andersen P.M., Nilsson P., Ala-Hurula V., Keränen M.-L., Tarvainen I., Haltia T., Nilsson L., Binzer M., Forsgren L., Marklund S.L. Amyotrophic lateral sclerosis associated with homozygosity for an Asp90Ala mutation in CuZn-superoxide dismutase. Nat. Genet. 1995, 10:61-66.
2. Andersen P.M., Forsgren L., Binzer M., Nilsson P., Ala-Hurula V., Keränen M.-L., Bergmark L., Saarinen A., Haltia T., Tarvainen I., Kinnunen E., Udd B., Marklund S.L. Autosomal recessive adult-onset ALS associated with homozygosity for Asp90Ala CuZn-superoxide dismutase mutation. A clinical and genealogical study of 36 patients. Brain 1996, 119:1153-1172.
3. Andersen P.M., Nilsson P., Keränen M.-L., Forsgren L., Hägglund J., Karlsborg M., Ronnevi L.-O., Gredal O., Marklund S.L. Phenotypic heterogeneity in MND-patients with CuZn-superoxide dismutase mutations in Scandinavia. Brain 1997, 10:1723-1737.
4. Andersen P.M., Sims K.B., Xin W.W., Kiely R., O'Neill G., Ravits J., Pioro E., Harati Y., Brower R.D., Levine J.S., Heinicke H.U., Seltzer W., Boss M., Brown R.H. Sixteen novel mutations in the gene encoding CuZn-superoxide dismutase in ALS. Amyotroph. Lateral Scler. Other Motor Neuron Disord. 2003, 2:62-73.
5. Andersen P.M., Borasio G.D., Dengler R., Hardiman O., Kollewe K., Leigh P.N., Pradat P.F., Silani V., Tomik B. EFNS task force on management of amyotrophic lateral sclerosis: guidelines for diagnosing and clinical care of patients and relatives. Eur. J. Neurol. 2005, 12(12):921-938.
6. Andersen P.M. Amyotrophic lateral sclerosis associated with mutations in the CuZn-superoxide dismutase gene. Curr. Neurol. Neurosci. Rep. 2006, 6:37-46.
7. Bylesjo M., Rantalainen M., Cloarec O., Nicholson J.K., Holmes E., Trygg J. OPLS discriminant analysis: combining the strengths of PLS-DA and SIMCA classification. J. Chemometrics 2006, 20:341-351.
8. Eisen A., Mezei M., Stewart H.G., Fabros M., Gibson G., Andersen P.M. SOD1 gene mutations in ALS patients in British Columbia, Canada: clinical features, neurophysiology and ethical issues in management. ALS 2008, 9:108-119.
9. Eriksson L., Trygg J., Wold S. CV-ANOVA for significance testing of PLS and OPLS® models. J. Chemom. 2008, 22(11-12):594-600.
10. van Es M.A., Dahlberg C., Birve A., Veldink J.H., Marklund S.L., van den Berg L., Andersen P.M. Large scale SOD1 mutation screening provides evidence for genetic heterogeneity in ALS. J. Neurol. Neurosurg. Psychiatry 2010, 81(5):562-566.
11. Felbecker A., Camu W., Valdmanis P.N., Sperfeld A.-D., Waibel S., Winter S., Birve A., Steinbach P., Kassubek J., Rouleau G.A., Ludolph A.C., Andersen P.M. Four familial ALS pedigrees discordant for two SOD1 gene mutations: are all SOD1 gene mutations pathogenic?. J. Neuro. Neurosurg. Psychiatry 2010, 81(5):572-577. Submitted.
12. Greenway M.J., Andersen P.M., Russ C., Ennis S., Cashman S., Donaghy C., Paterson V., Swingler R., Kieran D., Prehn J., Morrison K.E., Green A., Acharya K.R., Brown R.H., Hardiman O. Loss-of-function ANG mutations segregate with familial and 'sporadic' amyotrophic lateral sclerosis. Nat. Genet. 2006, 38:411-413.
13. Gianni F., Battistini S., Mancuso M., et al. D90A-SOD1 mutation in ALS: The first report of heterozygous Italian patients and unusual findings. ALS 2009, 1-4. Mar 10, (epub ahead of print).
14. Gieger C., Geistlinger L., Altmaier E., et al. Genetics meets metabolomics: a Genome-Wide Association Study of Metabolite Profiles in Human Serum. PLoS Genetics 2008, 4(11):e1000282.
15. Jonsson A., Graffmo K.S., Brännström T., Nilsson P., Andersen P.M., Marklund S.L. Motor neuron disease in mice expressing the wild type-like D90A mutant superoxide dismutase-1. J. Neuropathol. Exp. Neurol. 2006, 65:1126-1136.
16. Jonsson P., Johansson A.I., Gullberg J., Trygg J., A J, Grung B., Marklund S.L., Sjostrom M., Antti H., Moritz T. High-throughput data analysis for detecting and identifying differences between samples in GC/MS-based metabolomic analyses. Anal. Chem. 2005, 77(17):5635-5642.
17. Jonsson P., Johansson E.S., Wuolikainen A., Lindberg J., Schuppe-Koistinen I., Kusano M., et al. Predictive metabolite profiling applying hierarchical multivariate curve resolution to GC-MS data-a potential tool for multi-parametric diagnosis. J. Proteome Res. 2006, 5(6):1407-1414.
18. Maekawa S., Leigh P.N., King A., et al. TDP-43 is consistently co-localized with ubiquitinated inclusions in spradic and Guam amyotrophic lateral sclerosis but not in familial amyotrophic lateral sclerosis with and without SOD1 mutations. Neuropathology 2009, 29(6):672-683.
19. Parton M.J., Broom W., Andersen P.M., et al. D90A-SOD1 mediated amyotrophic lateral sclerosis and the "protective factor": a single founder for all cases with evidence for a Cis-acting disease-modifier in the recessive haplotype. Hum. Mutat. 2002, 20:473-480.
20. Sanelli T., Xiao S., Horne P., Bilbao J., Zinman L., Robertson J. Evidence that TDP-43 is not the major ubiquitinated target within the pathological inclusions of amyotrophic lateral sclerosis. J. Neuropathol. Exp. Neurol. 2007, 66:1147-1153.
21. Skvortsova V., Limborska S.A., Slominsky P.A., et al. Sporadic ALS associated with the D90A CuZn superoxide dismutase mutation in Russia. Eur. J. Neurol. 2001, 8:167-172.
22. Sumner L.W., Amberg A., Barrett D., Beale M.H., Beger R., Daykin C.A., Fan T.W.M., Fiehn O., Goodacre R., Griffin J.L., Hankemeier T., Hardy N., Harnly J., Higashi R., Kopka J., Lane A.N., Lindon J.C., Marriott P., Nicholls A.W., Reily M.D., Thaden J.J., Viant M.R. Proposed minimum reporting standards for chemical analysis. Metabolomics 2007, 3(3):211-221.
23. Trygg J., Wold S. Orthogonal projections to latent structures (O-PLS). J. Chemom. 2002, 16(3):119-128.
24. Vance C., Rogelj B., Hortobágyi T., et al. Mutations in FUS, an RNA processing protein cause familial amyotrophic lateral sclerosis type 6. Science 2009, 323:1208-1211.
25. Weber M., Eisen A., Stewart H.G., Andersen P.M. Preserved slow conducting corticomotoneuronal projections in ALS patients with autosomal recessive D90A CuZn-SOD mutation. Brain 2000, 123:1505-1515.
26. Wuolikainen A., Hedenström M., Moritz T., Marklund S.L., Antti H., Andersen P.M. Optimization of procedures for collecting and storing of CSF for studying the metabolome in ALS. Amyotroph. Lateral Scler. 2009, 10(4):229-236.
27. Wuolikainen A., Moritz T., Marklund S., Antti H., Andersen P.M. Disease-related changes in the cerebrospinal fluid metabolome in a case-control study of amyotrophic lateral sclerosis. PLoS One 2011, 6(4):e17947. Apr 4.
28. Zetterberg H., Jacobsson J., Rosengren L., Blennow K., Andersen P.M. CSF neurofilament light levels in amyotrophic lateral sclerosis: impact of SOD1 genotype. Eur. J. Neurol. 2007, 14:1329-1333.
29. Jonsson P.A., Bäckstrand Å., Andersen P.M., Jacobsson J., Parton M., Shaw C.E., Swingler R., Shaw P.J., Robberecht W., Ludolph A., Siddique T., Skvortsova V., Marklund S.L. CuZn-superoxide dismutase in D90A heterozygotes from recessive and dominant ALS pedigrees. Neurobiol Dis 2002, 10:327-333.
30. Jonsson P.A., Graffmo K.S., Andersen P.M., Marklund S.L., Brännström T. Superoxide dismutase in amyotrophic lateral sclerosis patients homozygous for D90A mutation. Neurobiol Dis 2009, 36:421-424.